What is the relationship between tofacitinib and Shangjie?

Tofacitinib(Tofacitinib) is a JAK inhibitor drug that is widely used to treat immune diseases such as rheumatoid arthritis and psoriatic arthritis. Tofacitinib slows down the excessive response of the immune system by inhibiting the JAK signaling pathway, thereby helping to control disease activity and improve patients' symptoms. Shangjie is the trade name of tofacitinib in the Chinese market. The two are the same drug, and the only difference lies in the trade name.

In short, Shangjie is just the brand name of tofacitinib in China. Their drug ingredients, pharmacological effects, indications and treatment mechanisms are exactly the same. Launched by Pfizer and approved by the China Food and Drug Administration, Shangjie has become a commonly used drug for rheumatoid arthritis, psoriatic arthritis and other immune system diseases. The launch of this drug has greatly improved the options for Chinese patients in the treatment of immune diseases, especially for patients who have poor response to traditional treatments. Shangjie provides them with new treatment hope.

The mechanism of action of tofacitinib is mainly to regulate the immune system by inhibitingJAK tyrosine kinase, thereby reducing the inflammatory response. When treating diseases such as rheumatoid arthritis, tofacitinib can significantly slow the progression of the disease, reduce joint swelling, pain and stiffness, and help patients regain their ability to move. In this way, tofacitinib improves the quality of life for many patients, especially those who have been affected by arthritis for a long time.

In general, there is no essential difference between Shangjie and tofacitinib. Shangjie is just the trade name of tofacitinib in China. Regardless of which name is used, patients receive the same therapeutic benefits and drug ingredients. When choosing a drug, patients should make decisions based on their doctor's recommendations and personal treatment needs without worrying about differences in drug names.

Reference materials:https://www.xeljanz.com/